Trial update
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease: registry status update
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.